|
ZNF746 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.871700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.523800E-02 |
| Normal-vs-Stage2 |
9.920000E-02 |
| Normal-vs-Stage3 |
3.088200E-01 |
| Normal-vs-Stage4 |
4.788200E-01 |
| Stage1-vs-Stage2 |
7.297400E-01 |
| Stage1-vs-Stage3 |
5.017800E-01 |
| Stage1-vs-Stage4 |
2.717000E-01 |
| Stage2-vs-Stage3 |
4.741400E-01 |
| Stage2-vs-Stage4 |
3.010000E-01 |
| Stage3-vs-Stage4 |
7.523400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.425500E-02 |
| Normal-vs-AfricanAmerican |
6.975700E-02 |
| Normal-vs-Asian |
1.286630E-01 |
| Caucasian-vs-AfricanAmerican |
5.120600E-01 |
| Caucasian-vs-Asian |
7.551200E-01 |
| AfricanAmerican-vs-Asian |
6.867000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.792400E-02 |
| Normal-vs-Female |
7.800000E-02 |
| Male-vs-Female |
5.928400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.382400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.154820E-01 |
| Normal-vs-Age(61-80Yrs) |
2.612600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.755800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.097000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.117600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.392600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.336200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.663200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.959200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.973300E-04 |
| Classical-VS-Follicular |
9.847200E-01 |
| Classical-VS-Other |
4.903600E-01 |
| Classical-VS-Normal |
1.326010E-02 |
| Tall-VS-Follicular |
7.039300E-03 |
| Tall-VS-Other |
3.620000E-01 |
| Tall-VS-Normal |
1.915960E-01 |
| Follicular-VS-Other |
6.258600E-01 |
| Follicular-VS-Normal |
9.426300E-02 |
| Other-VS-Normal |
8.509600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.908100E-02 |
| Normal-vs-N1 |
6.846200E-01 |
| N0-vs-N1 |
1.582560E-01 |
|
|
